Creo Medical Group PLC (AIM: CREO)

Market Cap	77.41M
Revenue (ttm)	30.30M
Net Income (ttm)	-22.40M
Shares Out	402.15M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,393
Open	16.50
Previous Close	16.25
Day's Range	16.00 - 16.50
52-Week Range	12.00 - 50.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 13, 2024

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; M...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 287
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

In 2023, Creo Medical Group's revenue was 30.80 million, an increase of 13.24% compared to the previous year's 27.20 million. Losses were -21.70 million, -19.33% less than in 2022.